Resmed Inc. buy Needham & Company LLC
Start price
06.09.23
/
50%
€143.10
Target price
06.09.24
-
Performance (%)
55.49%
End price
07.09.24
€222.50
Summary
This prediction ended on 07.09.24 with a price of €222.50. With a performance of 55.49% the BUY prediction by Needham___Company_LL was a big success. Dividends of €1.82 are taken into consideration when calculating the performance. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Resmed Inc. | -2.154% | -2.154% | 2.692% |
| iShares Core DAX® | 0.789% | 1.975% | 13.390% |
| iShares Nasdaq 100 | 4.226% | 4.344% | 39.717% |
| iShares Nikkei 225® | 3.285% | 6.991% | 49.894% |
| iShares S&P 500 | 2.496% | 2.759% | 30.229% |
Comments by Needham___Company_LL for this prediction
In the thread Resmed Inc. diskutieren
ResMed Inc. (NYSE: RMD) was upgraded by analysts at Needham & Company LLC from a "hold" rating to a "buy" rating.
Ratings data for RMD provided by MarketBeat
In the thread Trading Resmed Inc.
Die von Needham___Company_LL gewählte maximale Laufzeit wurde überschritten